10-Q: Heliogen Reports Q1 2024 Results Amidst Delisting and Going Concern Concerns

Sentiment:

Quarterly Report


Heliogen's Q1 2024 results show a net loss of $15.2 million and ongoing concerns about the company's ability to continue as a going concern, alongside its delisting from the NYSE.

Capital raiseThe company is actively assessing various avenues to secure additional capital, including, but not limited to, the issuance of debt, equity or both.Heliogen has engaged a financial advisor to assist in this process.
Worse than expectedThe company's net loss increased compared to the same period last year.Total revenue decreased year-over-year.Operating expenses increased significantly.There is substantial doubt about the company's ability to continue as a going concern.

Summary

  • Heliogen reported a net loss of $15.2 million for the first quarter of 2024, compared to a $10.5 million loss in the same period last year.
  • The company's total revenue decreased to $1.5 million from $1.9 million year-over-year, with a reduction in grant revenue offsetting a slight increase in services revenue.
  • Operating expenses increased to $16.2 million, primarily due to a one-time reversal of share-based compensation in the prior year.
  • Heliogen's cash and cash equivalents stood at $58.2 million, with total liquidity at $60.7 million as of March 31, 2024.
  • The company used $14.3 million in operating activities during the quarter.
  • There is substantial doubt about Heliogen's ability to continue as a going concern due to operating losses and significant cash outflows.
  • The company is exploring cost-saving measures and seeking additional capital through debt or equity financing.
  • Heliogen's stock and warrants have been delisted from the NYSE and are now trading on the OTCQX market.

Sentiment

Score: 2

Explanation: The document presents a very negative outlook due to significant losses, declining revenue, increased operating expenses, delisting from the NYSE, and a going concern warning. The company's financial health is precarious, and its future is highly uncertain.

Positives

  • Services revenue increased slightly to $1.0 million, up from $0.9 million in the same quarter last year.
  • The company is actively exploring cost-saving opportunities.
  • Heliogen is seeking additional capital through debt or equity financing.
  • The company has a $4.0 million award from the U.S. Department of Energy to accelerate the development of a solar thermal calciner.

Negatives

  • The company experienced a net loss of $15.2 million in Q1 2024.
  • Total revenue decreased to $1.5 million, down from $1.9 million in Q1 2023.
  • Operating expenses increased to $16.2 million.
  • There is substantial doubt about the company's ability to continue as a going concern.
  • Heliogen's stock and warrants have been delisted from the NYSE.
  • The company used $14.3 million in operating activities during the quarter.

Risks

  • Heliogen may not have sufficient resources to fund its cash obligations for the next 12 months.
  • The company's ability to access sources of capital is uncertain.
  • The delisting from the NYSE could negatively impact the company's ability to access equity markets and obtain financing.
  • The company faces risks related to market acceptance of its products and services.
  • The company's financial projections and business metrics are subject to uncertainty.
  • The company is exposed to supply chain disruptions.
  • The company is subject to the outcome of any known and unknown litigation and regulatory proceedings.

Future Outlook

Heliogen anticipates that it may not have sufficient resources to fund its cash obligations for the next 12 months and is exploring various cost-saving opportunities and seeking additional capital.

Management Comments

  • Management believes the information provided is relevant to an assessment and understanding of the company's consolidated results of operations and financial condition.
  • Management is exploring various cost saving opportunities and intends to continue seeking opportunities to generate additional revenue through its commercialization of engineering services.
  • Management has engaged a financial advisor and is actively assessing various avenues to secure additional capital, including, but not limited to, the issuance of debt, equity or both.

Industry Context

Heliogen's challenges reflect broader difficulties in the renewable energy sector, particularly for companies developing novel technologies that require significant capital investment and face market adoption hurdles. The delisting from the NYSE and the going concern warning highlight the financial pressures faced by companies in this space.

Comparison to Industry Standards

  • Heliogen's financial performance is significantly below industry standards for publicly traded renewable energy companies, many of which are reporting revenue growth and improved profitability.
  • Companies like First Solar and SunPower, while facing their own challenges, have demonstrated more robust revenue streams and better control over operating expenses.
  • Heliogen's reliance on a few key customers and its struggle to secure consistent revenue streams are not typical of more established players in the solar energy sector.
  • The company's high operating expenses relative to revenue are a major concern when compared to industry benchmarks.
  • The delisting from the NYSE is a significant negative event, as most comparable companies maintain their listings on major exchanges.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Financial OfficerSagar KuradaPhelps Morris2024-04-01Resignation of previous CFO
Interim Chief Financial OfficerNAAlan Gahm2024-01-11Interim appointment after CFO resignation
Chief Accounting OfficerNANA2024-01-26Resignation of previous CAO

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Stockholder Rights Plan AmendmentThe Rights Agreement was amended to extend the final expiration date by one year and change the definition of Exercise Price.2024-04-16The amendment is intended to reduce the likelihood that any entity, person or group gains control of Heliogen through open market accumulation without paying all stockholders an appropriate control premium.

Legal Proceedings

  • The company is involved in various claims and lawsuits arising in the normal course of business, but they are not expected to have a material effect on the consolidated financial statements.

Related Party Transactions

  • Heliogen recognized $86 thousand of services revenue from NantG Power, LLC, an affiliated sister-company, during the three months ended March 31, 2024.

Stakeholder Impact

  • Shareholders are negatively impacted by the delisting from the NYSE and the going concern warning.
  • Employees may be affected by potential cost-saving measures and headcount reductions.
  • Customers may be concerned about the company's ability to fulfill its contracts.
  • Suppliers and creditors face increased risk due to the company's financial instability.

Next Steps

  • The company will continue to explore cost-saving opportunities.
  • Heliogen will seek additional capital through debt or equity financing.
  • The company will continue to comply with public company SEC regulations and other NYSE listing requirements.
  • The company will continue to develop and commercialize its technology.

Key Dates

DateDescription
2022-03-28Date of the Commercial-Scale Demonstration Agreement (CSDA) with Woodside and the Collaboration Agreement with Woodside.
2023-03-24Heliogen entered into an agreement with NantG Power, LLC for front-end concept design and R&D engineering services.
2023-03-26Heliogen's Annual Report on Form 10-K for the year ended December 31, 2023 was filed with the SEC.
2023-04-16The Board of Directors declared a dividend of one preferred share purchase right for each outstanding share of common stock and adopted a limited duration stockholder rights plan.
2023-08-31The company effected a 1-for-35 reverse stock split of the company's common stock.
2023-11-07Heliogen received a letter from the NYSE notifying them of delisting proceedings.
2023-11-08Heliogen's common stock and public warrants began trading on the OTC market.
2024-01-11The Chief Financial Officer resigned and an Interim Chief Financial Officer was appointed.
2024-01-26The Chief Accounting Officer resigned and a new Chief Accounting Officer was appointed.
2024-03-25Executive Employment Agreement between Phelps Morris and Heliogen, Inc.
2024-03-31End of the first quarter of 2024.
2024-04-01A new Chief Financial Officer was appointed.
2024-04-15Heliogen notified the NYSE of its intent to withdraw its appeal of the delisting determination.
2024-04-16The Rights Agreement was amended to extend the final expiration date by one year.
2024-04-17The Rights will now expire on this date.
2024-05-02Date of share count.
2024-05-08Date of report.

Keywords

Heliogen, solar energy, concentrated solar power, financial results, delisting, going concern, revenue, net loss, operating expenses, liquidity, capital raise, OTC, warrants

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.